lobbying_activities: 2635409
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2635409 | 5251277d-1ddc-4e4e-a54d-5a72cebdc446 | Q2 | PHARMAVITE LLC | 286074 | PHARMAVITE LLC | 2021 | second_quarter | CSP | H.R. 1816, Information Transparency & Personal Data Control Act, a bill to require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes; all provisions relating to dietary supplements. S. 1667, Social Media Privacy Protection and Consumer Rights Act, a bill to protect the privacy of users of social media and other online platforms; all provisions relating to dietary supplements. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-07-12T15:28:07.197000-04:00 |